Assessing Safety and Efficacy of Sintilimab and Metformin Combination Therapy in SCLC

Clinical trial NCT03994744 · UNKNOWN

Trial details

NCT number: NCT03994744
Sponsor: Hunan Cancer Hospital
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Small-cell Lung Cancer Small Cell Lung Carcinoma Small Cell Lung Cancer Recurrent Small Cell Lung Cancer Extensive Stage

Start date: 2019-08-20
Primary completion: 2021-08-01
Enrollment: 68

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.